Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 165.5K | -1.1M | 410.2K | 1.0M |
Other operating expenses | 74.6K | 1.3M | 124.7K | 152.0K |
Operating income | -240.1K | -230.2K | -534.9K | -1.2M |
Non operating interest income | ||||
Income | 4.5K | 23.6K | 0 | 19.7K |
Expense | — | — | — | — |
Other income expense | 1.2M | -17.0M | -41.9K | 410.2K |
Pretax income | 980.8K | -17.2M | -576.8K | -743.9K |
Tax provision | — | — | — | — |
Net income | 980.8K | -17.2M | -576.8K | -743.9K |
Basic EPS | 0.0 | — | 0.0 | 0.0 |
Diluted EPS | 0.0 | — | 0.0 | 0.0 |
Basic average shares | 30.3M | — | 28.5M | 17.7M |
Diluted average shares | 30.3M | — | 28.5M | 17.7M |
EBITDA | -249.4K | 16.8M | -493.0K | -1.2M |
Net income from continuing op. | 980.8K | -17.2M | — | -743.9K |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |